Principles of pharmacoeconomics:
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Cincinnati, OH
Harvey Whitney Books
1996
|
| Edition: | 2. ed. |
| Subjects: | |
| Physical Description: | VII, 302 S. graph. Darst. |
| ISBN: | 0929375173 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010889459 | ||
| 003 | DE-604 | ||
| 005 | 20090629 | ||
| 007 | t | ||
| 008 | 960806s1996 xxud||| |||| 00||| eng d | ||
| 020 | |a 0929375173 |9 0-929375-17-3 | ||
| 035 | |a (OCoLC)34192518 | ||
| 035 | |a (DE-599)BVBBV010889459 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-703 |a DE-12 |a DE-19 |a DE-521 | ||
| 050 | 0 | |a RM263.P73 1996 | |
| 082 | 0 | |a 338.4/361558 |2 20 | |
| 082 | 0 | |a 338.4/361558 20 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 100 | 1 | |a Bootman, J. Lyle |e Verfasser |0 (DE-588)129516694 |4 aut | |
| 245 | 1 | 0 | |a Principles of pharmacoeconomics |c J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| 250 | |a 2. ed. | ||
| 264 | 1 | |a Cincinnati, OH |b Harvey Whitney Books |c 1996 | |
| 300 | |a VII, 302 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Clinical trials |2 gtt | |
| 650 | 7 | |a Epidemiologie |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Kostenanalyse |2 gtt | |
| 650 | 7 | |a Kwaliteit van het bestaan |2 gtt | |
| 650 | 4 | |a Chemotherapy -- Economic aspects | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Pharmaceutical policy | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 1 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 2 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Townsend, Raymond J. |d 1991- |e Verfasser |0 (DE-588)138534012 |4 aut | |
| 700 | 1 | |a McGhan, William F. |e Verfasser |0 (DE-588)129516686 |4 aut | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007281434 | ||
Record in the Search Index
| _version_ | 1804125378794487808 |
|---|---|
| any_adam_object | |
| author | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. |
| author_GND | (DE-588)129516694 (DE-588)138534012 (DE-588)129516686 |
| author_facet | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. |
| author_role | aut aut aut |
| author_sort | Bootman, J. Lyle |
| author_variant | j l b jl jlb r j t rj rjt w f m wf wfm |
| building | Verbundindex |
| bvnumber | BV010889459 |
| callnumber-first | R - Medicine |
| callnumber-label | RM263 |
| callnumber-raw | RM263.P73 1996 |
| callnumber-search | RM263.P73 1996 |
| callnumber-sort | RM 3263 P73 41996 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | QR 525 QX 700 |
| ctrlnum | (OCoLC)34192518 (DE-599)BVBBV010889459 |
| dewey-full | 338.4/361558 338.4/36155820 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/361558 338.4/361558 20 |
| dewey-search | 338.4/361558 338.4/361558 20 |
| dewey-sort | 3338.4 6361558 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | 2. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02270nam a2200625 c 4500</leader><controlfield tag="001">BV010889459</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090629 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960806s1996 xxud||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0929375173</subfield><subfield code="9">0-929375-17-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34192518</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010889459</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM263.P73 1996</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/361558</subfield><subfield code="2">20</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/361558 20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bootman, J. Lyle</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129516694</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Principles of pharmacoeconomics</subfield><subfield code="c">J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cincinnati, OH</subfield><subfield code="b">Harvey Whitney Books</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 302 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kostenanalyse</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kwaliteit van het bestaan</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemotherapy -- Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Townsend, Raymond J.</subfield><subfield code="d">1991-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)138534012</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McGhan, William F.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129516686</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007281434</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV010889459 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:00:37Z |
| institution | BVB |
| isbn | 0929375173 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007281434 |
| oclc_num | 34192518 |
| open_access_boolean | |
| owner | DE-703 DE-12 DE-19 DE-BY-UBM DE-521 |
| owner_facet | DE-703 DE-12 DE-19 DE-BY-UBM DE-521 |
| physical | VII, 302 S. graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Harvey Whitney Books |
| record_format | marc |
| spelling | Bootman, J. Lyle Verfasser (DE-588)129516694 aut Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan 2. ed. Cincinnati, OH Harvey Whitney Books 1996 VII, 302 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Clinical trials gtt Epidemiologie gtt Geneesmiddelen gtt Kostenanalyse gtt Kwaliteit van het bestaan gtt Chemotherapy -- Economic aspects Pharmaceutical industry Pharmaceutical policy Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmakotherapie (DE-588)4076066-2 s Gesundheitsökonomie (DE-588)4130935-2 s DE-604 Kosten-Nutzen-Analyse (DE-588)4032589-1 s Arzneimittelentwicklung (DE-588)4143176-5 s Townsend, Raymond J. 1991- Verfasser (DE-588)138534012 aut McGhan, William F. Verfasser (DE-588)129516686 aut |
| spellingShingle | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. Principles of pharmacoeconomics Clinical trials gtt Epidemiologie gtt Geneesmiddelen gtt Kostenanalyse gtt Kwaliteit van het bestaan gtt Chemotherapy -- Economic aspects Pharmaceutical industry Pharmaceutical policy Arzneimittelentwicklung (DE-588)4143176-5 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4130935-2 (DE-588)4032589-1 (DE-588)4076066-2 (DE-588)4143413-4 |
| title | Principles of pharmacoeconomics |
| title_auth | Principles of pharmacoeconomics |
| title_exact_search | Principles of pharmacoeconomics |
| title_full | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_fullStr | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_full_unstemmed | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_short | Principles of pharmacoeconomics |
| title_sort | principles of pharmacoeconomics |
| topic | Clinical trials gtt Epidemiologie gtt Geneesmiddelen gtt Kostenanalyse gtt Kwaliteit van het bestaan gtt Chemotherapy -- Economic aspects Pharmaceutical industry Pharmaceutical policy Arzneimittelentwicklung (DE-588)4143176-5 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Clinical trials Epidemiologie Geneesmiddelen Kostenanalyse Kwaliteit van het bestaan Chemotherapy -- Economic aspects Pharmaceutical industry Pharmaceutical policy Arzneimittelentwicklung Gesundheitsökonomie Kosten-Nutzen-Analyse Pharmakotherapie Aufsatzsammlung |
| work_keys_str_mv | AT bootmanjlyle principlesofpharmacoeconomics AT townsendraymondj principlesofpharmacoeconomics AT mcghanwilliamf principlesofpharmacoeconomics |